image

The best stocks to buy since 1993

Our latest issue will be released in 4 days, don't miss out!

ITE

January 2013

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ITE
  • Price:
  • 220p
• Out of the dozen or so companies we either spoke to or met with during December, one where we came away feeling extremely positive about its prospects for 2013 was ITE (ITE; 220p). The company is the world's seventh largest business-to-business exhibition operator behind Reed and UBM but is bigger than Informa and EMAP. These peers might all be better favoured by investors because despite being quoted on the Full List in London, ITE holds most of its events in Russia, the former Soviet countries, Turkey and India and investors might  think it is several notches more speculative. But against that ITE has solid attractions. Its business model is relatively simple; it will lease a trad ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe